-
DelMar Pharmaceuticals' (DMPI) Management on Q2 2018 Results - Earnings Call Transcript
21 Feb 2018 03:33 GMT
… joining us this afternoon for DelMar Pharmaceuticals’ Business Update Conference Call to … discussed in the periodic reports DelMar Pharmaceuticals files with the Securities and … the company before the original IPO, Dennis and Jeff were both …
-
Week In Review: Chipscreen Gains 367% Following $148 Million Shanghai STAR IPO
18 Aug 2019 15:00 GMT
… first trading session following its IPO on the Shanghai STAR … the first 25 STAR Board IPOs hit the market last … diseases. It priced its IPO 27% above its original target … global rights only for asthma.
DelMar Pharmaceuticals (NASDAQ:DMPI) of Vancouver and …
-
The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO
27 Jun 2019 11:55 GMT
… June 26)
Invest in IPO shares before the stock hits … /ADR (NASDAQ: CYAD)
DelMar Pharmaceuticals Inc (NASDAQ: DMPI)(announced an … fibrosis.
On The Radar
IPOs
Adaptive Biotechnologies, which translates … disease, priced its upsized IPO of 15 million shares at …
-
Benzinga's Daily Biotech Pulse: FDA Greenlights Tandem Diabetes' Insulin Pump, More IPOs On Tap
25 Jun 2018 10:08 GMT
… Biosciences Inc (NASDAQ: CLRB)
DelMar Pharmaceuticals Inc (NASDAQ: DMPI)
Enzo … Conferences, Clinical Trials And IPOs
Stocks In Focus
FDA … Radar
IPOs
Autolus Therapeutics priced its 8.23 million initial public offering … 4.33 million share-IPO at $15 per share …
-
60 Stocks Moving In Monday's Mid-Day Session
17 Aug 2020 17:07 GMT
… on Friday after pricing its IPO at $16 per share.
Microbot … for $7.30 per ADS.
DelMar Pharmaceuticals Inc (NASDAQ: DMPI) climbed 8% …
-
The Week Ahead In Biotech: Karyopharm, Zogenix, Heron, Chiasma On The Radar Ahead Of FDA Decisions
21 Jun 2020 19:24 GMT
… flurry of activity on the IPO front.
The following are key … BNT122 in multiple solid tumors.
DelMar Pharmaceuticals Inc (NASDAQ: DMPI) is due …
-
The Week Ahead In Biotech: Clinical Readouts In Focus As Earnings Wind Down
17 Nov 2019 13:50 GMT
… in recurrent glioblastoma multiforme (Friday)
DelMar Pharmaceuticals Inc (NASDAQ: DMPI) – Updated Phase … (NASDAQ: ENTA) (after the close)
IPO Quiet Period Expiry
TFF Pharmaceuticals …